Table 1.
Baseline demographics of study subjects before PSM.
| Characteristics | VA (N = 81), n (%) | VBQT (N = 420), n (%) | P value |
|---|---|---|---|
| Gender | |||
| Male | 40 (49.4) | 167 (39.8) | .107 |
| Female | 41 (50.6) | 253 (60.2) | |
| Age (years, mean ± SD) | 43.00 ± 11.80 | 44.18 ± 13.40 | .423 |
| Patient type | |||
| Outpatient | 51 (63.0) | 335 (79.8) | .001 |
| Inpatient | 30 (37.0) | 85 (20.2) | |
| BMI (kg/m2, mean ± SD) | 23.67 ± 3.12 | 24.04 ± 3.18 | .327 |
| Smoking | 17 (21.0) | 60 (14.3) | .126 |
| Alcohol drinking | 25 (30.9) | 113 (26.9) | .465 |
| Number of comorbidities | |||
| 0 | 68 (84.0) | 345 (82.1) | .479 |
| 1 | 12 (14.8) | 51 (12.1) | |
| 2 | 1 (1.2) | 19 (4.5) | |
| More than 2 | 0 (0.0) | 5 (1.2) | |
| Endoscopic findings | |||
| No gastroscopy | 26 (32.1) | 172 (41.0) | .080 |
| Only non-atrophic gastritis | 25 (30.9) | 112 (26.7) | |
| Only atrophic gastritis | 24 (29.6) | 68 (16.2) | |
| Mainly Gastritis and esophagitis | 2 (2.5) | 18 (4.3) | |
| Mainly gastritis and gastric ulcer and/or duodenal ulcer | 4 (4.9) | 24 (5.7) | |
| Mainly gastritis and globoduodenitis | 0 (0.0) | 9 (2.1) | |
| Mainly gastritis and cardiac polyp and/or gastric polyp | 0 (0.0) | 12 (2.9) | |
| Other complex diagnosis | 0 (0.0) | 5 (1.2) | |
Student t test, Chi-square and Fisher’s exact tests was used for statistical analysis. All results were considered significant if the P value was < .05.
BMI = body mass index, PSM = propensity score matching, SD = standard deviation, VA = vonoprazan-amoxicillin dual therapy, VBQT = vonoprazan-based bismuth-containing quadruple therapy.